Reported about 11 hours ago
Advanced Micro Devices (AMD) sees its stock price increase after analysts raised their target to $140, driven by positive GPU market outlook. In contrast, Sarepta Therapeutics (SRPT) suffers a significant decline following the death of a second patient in its gene therapy trial. Meanwhile, EchoStar's stock surges as President Trump calls for a resolution in a dispute with the FCC over wireless spectrum licenses, with the company facing potential bankruptcy if the issue isn't resolved.
Source: YAHOO